［7］ Greer DL. Evolving role of nondermatophytes in onychomycosis. Int J Dermatol, 1995,34:521－ 524.
［8］ Ginter G, Rieger E, Heigl K, et al. Increasing frequency of onychomycosis－ is there a change in the spectrum of infectious agents. Mycoses, 1996,39(Suppl 1):118－ 122.
［9］ Wang DL. Pathogen investigation on onychomycosis: a multicenter study. Chin J Dermatol, 1996,29:61－ 62.
［10］ Kam KM, Au WF, Wong PY, et al. Onychomycosis in Hong Kong. Int J Dermatol, 1997,36:757－ 761.
［11］ Ellis DH, Marley JE, Watson AB, et al. Significance of non－ dermatophyte moulds and yeasts in onychomycosis. Dermatology, 1997,194(Suppl 1):40－ 42.
［12］ Summerbell RC. Epidemiology and ecology of onychomycosis. Dermatology, 1997,194(Suppl 1):32－ 36.
［13］ Pié rard GE, Arrese JE, De Doncker P, et al. Present and potential diagnostic techniques in onychomycosis. J Am Acad Dermatol, 1996,34:273－ 277.
［14］ De Doncker P.Pharmacokenetics of orally administered antifungals in onychomycosis. Int J Dermatol, 1999,38(Suppl 2):20－ 27.
［15］Galgiani JN. Susceptibility testing of fungi: current status of the standardization process. Antimicrob Agents Chemother, 1993,37:2517－ 2521.
［16］ Elewski BE. Mechanisms of action of systemic antifungal agents. J Am Acad Dermatol, 1993,28:S28－ S34.
［17］ Pi
rard Franchimont C,Goffin V,Arrese JE, et al. Biometrology applied to cyanoacrylate skin surface strippings: a review of the Liè ge experience. Dermatol Clin, 1999,19:93－ 97.
［25］陈志强，徐文严，陈祥生，等.伊曲康唑在我国的应用：五年临床经验回顾.中华皮肤科杂志，1999，32：330－334.
上一页 1 2 3 [4] 5 下一页
